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Purpose: To synthesize a ternary cationic copolymer called CS-g-(PEI-b-mPEG) and characterize its features as a non-
viral siRNA carrier; in turn, to investigate the influence of small interfering RNA (siRNA) targeting IκB kinase subunit
β (IKKβ) on the proliferation of human Tenon’s capsule fibroblasts (HTFs) in vitro.
Methods: First, a novel cationic copolymer composed of low molecular weight, linear poly(ethyleneimine) [PEI] blocked
with polyethylene glycol (PEG) and grafted onto a chitosan (CS) molecule was synthesized. CS-g-(PEI-b-mPEG) was
then compacted with 21nt siRNA at various copolymer/siRNA charge (N/P) ratios, and the resulting complexes were
characterized by dynamic light scattering, gel electrophoresis, and serum incubation. Cell Titer 96® AQueous One Solution
cell proliferation assay was used to investigate the cytotoxicity of this cationic copolymer. Second, siRNAs targeting
IKKβ  (IKKΒ-siRNAs)  were  delivered  into  the  HTFs  using  CS-g-(PEI-b-mPEG)  as  the  vehicle.  Real-time  reverse
transcription polymerase chain reaction (RT–PCR) subsequently assessed the mRNA level of IKKβ, and western blot
assay was used to determine protein expression. After IKKB-siRNA transfection, Cell Titer 96® AQueous One Solution
cell proliferation assay was used to evaluate the proliferation of HTFs.
Results: The diameter of the CS-g-(PEI-b-mPEG)/siRNA complexes tended to decrease whereas their zeta potential
tended to increase as the N/P ratio increased. The CS-g-(PEI-b-mPEG) copolymer showed good siRNA binding ability
and high siRNA protection capacity. Furthermore, the copolymer presented remarkable transfection efficiency and showed
much less cytotoxicity than 25 kDa PEI. IKKB-siRNAs were successfully delivered into HTFs using CS-g-(PEI-b-mPEG)
as a vector. As a result, the expression of IKKβ was downregulated at both the mRNA and protein levels, and the activation
of nuclear factor-κB (NF-κB) in the HTFs was subsequently inhibited. Most impressively, the proliferation of HTFs was
also effectively suppressed through the blocking of the NF-κB pathway.
Conclusions: All the results demonstrate that CS-g-(PEI-b-mPEG) is a promising candidate for siRNA delivery, featuring
excellent biocompatibility, biodegradability, and transfection efficiency. The RNA interference (RNAi) strategy using
cationic copolymers as siRNA carriers will be a safe and efficient anti-scarring method following glaucoma filtration
surgery.
RNA interference (RNAi) was originally recognized as
an  evolutionary  conserved  defense  mechanism  in  higher
eukaryotic cells, and this system can easily and effectively
inhibit the expression of one specific gene [1]. The RNAi
process  is  mediated  through  small,  double-stranded  RNA
molecules  called  small  interfering  RNA  (siRNA),  which
specifically trigger the cleavage and subsequent degradation
of  their  target  mRNA  in  a  sequence-dependence  manner.
Hence, synthesis of the protein encoded by those mRNA is
prevented [2]. Recently, RNAi-mediated gene silencing has
also been shown to be efficient in mammalian cells, and this
has led to the increasing feasibility of RNAi technology for
the therapy of certain human diseases [3].
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The efficiency of RNAi mainly depends on the successful
delivery of intact siRNA into mammalian cells. However, due
to the low stability of siRNA against enzymatic degradation
and low permeability across cell membranes, the efficacy of
naked siRNA is insufficient. Therefore, it is necessary to
develop efficient and convenient methods for siRNA delivery.
Until now, viral delivery systems have been used as vectors
for  genes  in  many  studies  due  to  the  advantage  of  high
transfection efficacy, but the use of such delivery systems is
limited by endogenous recombination and host immunity [4].
Moreover, since ontogenesis and mortality have been reported
[5], concerns have been raised regarding the safety of using
viral vectors in gene therapy trials in humans. In light of these
problems, studies of alternative delivery strategies focus on
non-viral  systems  for  gene  delivery.  Recently,  cationic
copolymers have been demonstrated to be a promising non-
viral vector for transfecting nucleotides into various cell types
or  tissues  [6].  Among  these  cationic  polymers,
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2616polyethylenimine (PEI) is an effective gene carrier due to
PEI’s high charge density and endosomal disruption function,
but  it  is  difficult  to  achieve  both  the  goals  of  higher
transfection  efficiency  and  lower  cytotoxicity  with  PEI
homopolymers [7]. Various modifications of PEI have been
investigated to promote its nucleotide delivery ability as well
as to reduce its adverse effects on cell viability. It has been
shown that grafting PEI with nonionic hydrophilic polymers
such  as  polyethylene  glycol  (PEG)  could  be  an  effective
approach for minimizing the cationic toxicity of PEI and that
the cationic toxicity of PEI decreases as its molecular weight
decreases [8]. However, the transfection efficiency of the
PEGylated, low molecular weight PEI copolymer is lower
than that of 25 kDa PEI [9]. Chitosan (CS) is a non-toxic,
biodegradable  cationic  polymer  with  relatively  low
immunogenicity and especially good macro-adhesion. CS has
been  extensively  investigated  as  a  delivery  system  for
therapeutic  macromolecules,  nucleotides,  and  protein
molecules [10]. Thus, we hypothesize that a new copolymer
could be synthesized as a siRNA carrier that would have both
the  efficient  transfection  ability  of  PEI  and  the
biocompatibility of PEG and CS.
Glaucoma  is  an  eye  disease  usually  associated  with
increased  intraocular  pressure  that  leads  to  irreversible
functional impairment of the optic nerve. Filtration surgery to
enhance the drainage of aqueous humor is one of the most
effective  therapies  for  glaucoma  [11],  but  the  therapy’s
success rate is reduced by blockage of the surgically created
drainage channel by subconjunctival scarring that may occur
with  wound  healing  [12].  Fibroblasts  located  in  the
subconjunctival area play a major role in scar formation after
filtration  surgery  through  proliferation,  migration,  and
synthesis of the extracellular matrix (ECM). Thus, regulating
the biological activities of subconjunctival Tenon’s capsule
fibroblasts (TCFs) during the wound healing process is a
major anti-scarring strategy for glaucoma filtration surgery
[13]. Nuclear factor-κB (NF-κB) is a transcription factor that
is  also  a  positive  regulator  for  fibroblasts,  and  a  protein
complex called IκB kinase (IKK) is a critical regulator of the
activation of NF-κB [14,15]. Most studies on the role of the
NF-κB pathway in the regulation of cell proliferation have
used  immortal  cell  lines  (cells  capable  of  continuously
renewing themselves). In this study, we investigated whether
inhibiting the function of IKK and subsequently blocking the
signaling pathway of NF-κB could effectively manipulate the
activation  and  proliferation  of  TCFs  during  the  scarring
process following glaucoma filtration surgery.
In the study reported here, absorbable, low molecular
weight  PEI  was  blocked  with  polyethylene  glycol
monomethyl ether (mPEG) and grafted onto chitosan. As a
result,  a  novel  biodegradable  copolymer,  CS-g-(PEI-b-
mPEG), was synthesized. The properties of the CS-g-(PEI-b-
mPEG)/siRNA complexes such as particle size, zeta potential,
siRNA binding and protection capacity, transfection ability,
and cytotoxicity were studied, and IKKΒ-siRNAs were then
delivered  into  human  Tenon’s  capsule  fibroblasts  (HTFs)
using CS-g-(PEI-b-mPEG) as the vehicle. The expression of
IKKβ was detected at both the mRNA and protein levels after
the transfection of IKKΒ-siRNAs. We also investigated the
activation of NF-κB and the proliferation of HTFs after the
RNA interference process targeting IKKβ.
METHODS
Cell culture: HeLa (human cervix epithelial carcinoma) cells
were obtained from the American Type Culture Collection
(Number  CCL-2.1;  ATCC,  Rockville,  MD)  and  were
maintained in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco, Grand Island, NY) containing 10% fetal bovine serum
(FBS; HyClone, Logan, UT), 2 mM of L-glutamine, 100 IU/
ml of penicillin, 100 μg/ml of streptomycin, and 25 μg/ml of
amphotericin B (all from Sigma-Aldrich, St. Louis, MO) at
37 °C with 5% CO2, 95% humidified atmosphere.
Tissue explants of human Tenon’s capsule were obtained
from three male patients (aged 28, 39, and 62 without any
topical eye treatment) who had undergone trauma or cataract
surgery. Patients were informed of the nature and possible
consequences of the tissue removal procedure, and written,
informed consent was obtained. The tenets of the Declaration
of Helsinki were followed, and approval by the Sun Yat-sen
University Human Experimentation committee was granted.
HTFs were cultured by a previously reported method [16] with
some  modification,  as  described  below.  Cells  were
maintained  as  a  monolayer  at  37  °C  with  5%  CO2,  95%
humidified atmosphere in DMEM supplemented with 10%
FBS, 2 mM of L-glutamine, 100 IU/ml of penicillin, 100 μg/
ml of streptomycin, and 25 μg/ml of amphotericin B. Cells
between  passages  3  and  6  were  used  for  the  following
experiments.
Synthesis  and  characterization  of  CS-g-(PEI-b-mPEG):
Chitosan, (the weight-average molecular weight of chitosan
was 3.50×105 [Mw=3.50×105], which was measured by the
viscosity method and the degree of deacetylation of chitosan
was 88%, which was determined by proton nuclear magnetic
resonance [1H NMR]), was purified by a solvent precipitation
method. Polyethylene glycol monomethyl ether (mPEG, AR,
Mn=2000) was purchased from Sigma-Aldrich Chemie Gmbh
(Steinheim, Germany). Linear PEI (Mn=600) and branched
PEI (Mn=25,000) were obtained from Wako Pure Chemical
Industries,  Ltd.  (Osaka,  Japan).  CS-g-(PEI-b-mPEG)  was
synthesized by Jiang’s method with some modification [17],
and  the  steps  are  briefly  described  as  follows.  Di-block
copolymer,  PEI-b-mPEG,  was  synthesized  by  an  imine
reaction, and then the periodate ion, IO4
-, was used to oxidize
CS to produce dialdehyde. A novel, comb-like copolymer,
CS-g-(PEI-b-mPEG), was synthesized by an imine reaction
between the amino groups of PEI-b-mPEG and the aldehyde
groups of periodate-oxidized CS. The resultant product was
purified by dialysis against double deionized (DD) water with
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was 12 K; Spectrum, Houston, TX) for 72 h to remove the
unreacted PEI and mPEG and then freeze-dried for another 24
h. A schematic illustration of the synthesis process is shown
in Figure 1, and the structure of the newly synthesized CS-g-
(PEI-b-mPEG) was proved by 1H NMR and gel permeation
chromatography (GPC).
Preparation  of  CS-g-(PEI-b-mPEG)/siRNA  complexes:
IKKΒ-siRNA,  scrambled  siRNA,  and  fluorescein
isothiocyanate (FITC)-conjugated scrambled siRNA were all
synthesized  by  Ribobio  Co.  Ltd.  (Guangzhou,  China).
Lyophilized  siRNAs  were  dissolved  in  RNase-free  H2O
(pH=7.4) and incubated for 5 min at room temperature, and
the CS-g-(PEI-b-mPEG) copolymer was dissolved in serum-
free  DMEM  at  a  stock  concentration  of  1  mg/ml.
Subsequently, different concentrations of the CS-g-(PEI-b-
mPEG) solution were added into dissolved siRNA to make
complexes of various charge ratios. The charge ratio of CS-
g-(PEI-b-mPEG) and siRNA was expressed as the molar ratio
of the amine groups of the copolymer (representing positive
units)  to  the  phosphates  of  siRNA  (representing  negative
units) called the N/P ratio. The mixture was gently vortexed
for 10 s and incubated at room temperature for 30 min to allow
the formation of CS-g-(PEI-b-mPEG)/siRNA complexes.
Measurement of particle size and zeta potential: Dynamic
light scattering (DLS) with a Zetasizer Nano ZS instrument
(Malvern  Instruments,  Worcestershire,  UK)  was  used  to
measure the diameter and zeta potential of the CS-g-(PEI-b-
mPEG)/siRNA complexes with N/P ratios of 1, 3, 5, 10, and
20.  The  hydrodynamic  diameter  of  the  freshly  prepared
complexes was measured at 25 °C with a scattering angle of
90° (10 mW He-Ne Laser, 633 nm), and the zeta potential was
determined by the standard capillary electrophoresis cell of
Zetasizer Nano ZS at position 17.0 and at 25 °C. All the
average  values  were  performed  with  the  data  from  three
separate measurements.
Electrophoresis mobility assay: The binding degree between
CS-g-(PEI-b-mPEG)  and  siRNA  was  determined  by  4%
agarose  (low  melting  point)  gel  electrophoresis  [10].  The
complexes  were  prepared  at  N/P  ratios  of  0  (samples
containing siRNAs that did not compact with CS-g-(PEI-b-
mPEG) were considered as N/P ratio=0), 1, 3, 5, 10, and 20
as described above, and samples, each containing 0.133 μg
(1×10−2 nmol) of siRNAs, were loaded onto 4% agarose gel
together  with  1:6  dilution  of  the  loading  buffer.  The
electrophoresis was performed in TBE buffer (4.5 mM of Tris-
base, 1 mM of sodium EDTA, 4.5 mM of boric acid, pH=8.3)
at 55 V for 1 h. To visualize the siRNA, the gel was immersed
in 0.5 µg/ml of ethidium bromide solution (Sigma-Aldrich),
and the fluorescence images were captured under ultraviolet
(UV) illumination (Vilber Lourmat, France).
Serum resistance test: The ability of CS-g-(PEI-b-mPEG) to
protect  siRNA  against  enzymatic  degradation  was
investigated according to a previously reported method with
minor modifications [10]. The CS-g-(PEI-b-mPEG)/siRNA
complexes  containing  the  same  amount  of  siRNAs  were
prepared at an N/P ratio of 0 (naked siRNA), 1, 3, 5, 10, and
20. Subsequently, FBS was added as needed to achieve a final
concentration of 10%. The mixtures were incubated at 37 °C,
and at each determined time interval (2 h, 4 h, 8 h, 12 h, and
Figure 1. The synthesis schedule of CS-g-(PEI-b-mPEG) copolymer.
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at 70 °C for 5 min to inactivate the serum enzymes. Then, 5 µl
of heparin (1000 IU/ml) was added to displace the siRNAs
from the complexes before the mixtures were loaded onto a
15% polyacrylamide gel containing 7 M urea. Electrophoresis
was performed in TBE buffer at 200 V for 1 h. Afterward, gels
were  stained  in  a  1:10,000  dilution  of  SYBR®  Green  II
fluorescent RNA dye (Molecular Probe Inc., Eugene, OR) for
40 min, and Bio-Capt version 10.0 software (Vilber Lourmat,
France) was used to analyze the fluorescence intensity of each
band. All experiments were performed in triplicate, and the
fluorescence intensity of each band was compared with that
of the non-FBS treated siRNAs (which served as the control)
on the same gel.
In vitro transfection and cell viability assays: HeLa cells and
HTFs were plated in six well plates with a density of 6×105
cells per well and incubated for 12 h or 24 h (reaching 60%–
70% confluence). The culture media were then replaced with
DMEM  without  serum  or  with  antibiotics  2  h  before
transfection. The CS-g-(PEI-b-mPEG) and FITC-conjugated
siRNA complexes were prepared as described above, and the
N/P  ratios  were  performed  at  0  (naked  FITC-conjugated
siRNAs), 1, 3, 5, 10, and 20. A total volume of 2 ml of serum
and antibiotics-free DMEM-containing complexes was added
to each well, and the final concentration of siRNAs was 50
nM. After a 6 h incubation at 37 °C, the remaining media were
discarded, and cells were trypsinized and resuspended in PBS
at a density of 5×105 cells/ml for flow cytometry analysis. The
transfection  efficiency  was  calculated  by  measuring  the
percentage of FITC-labeled cells using a FACSAriaTM System
(BD Bioscience, Oxford, UK).
Cell Titer 96® AQueous One Solution cell proliferation
assay  (Promega,  Madison,  WI)  was  used  to  evaluate  cell
viability [18]. HTFs were seeded in 96 well plates with an
initial density of 5×103 cells per well and incubated for 24 h
(reaching  80%  confluence)  before  the  copolymers  were
added. Then, serum-supplied DMEM were replaced by 200 µl
of serum and antibiotic-free DMEM that contained various
concentrations (1, 5, 10, 50, and 100 μg/ml) of CS-g-(PEI-b-
mPEG) or 25 kDa PEI. The CS-g-(PEI-b-mPEG) or 25 kDa
PEI/siRNA complexes containing 100 nM of siRNAs were
prepared at an N/P ratio of 0 (only scrambled siRNAs), 1, 3,
5, 10, and 20, and their cytotoxicity was also evaluated. After
24 h incubation at 37 °C, the media were replaced with fresh
serum and antibiotic-free DMEM that contained 20 μl of Cell
Titer 96® AQueous One Solution Reagent (MTS). Finally, after
4 h of additional incubation, a micro-plate reader (Bio-Rad
Lab Inc., Hercules, CA) measured the absorbance of each well
at 570 nm. Cell viability was calculated according to the
following equation:
where OD570(sample) represents the average absorbance of cells
treated with media that contain different concentrations of
cationic polymers or cationic polymers/siRNA complexes,
and OD570(control) represents the average absorbance of cells
treated only with an equal volume of serum-free DMEM.
Delivery  of  IKKB-siRNA  into  human  Tenon’s  capsule
fibroblasts via CS-g-(PEI-b-mPEG):  Two pairs of siRNA
specifically  targeting  IKKβ  (IKKΒ-siRNA)  were  derived
from the coding sequence of the human IKKβ gene (GenBank
NM_001556) and were designed using a siRNA Target Finder
program. A BLAST search checked all the duplex sequences
and target sequences of these siRNAs to preclude sequences
with  significant  similarity  to  other  genes  in  the  human
genome. The duplex sequences of IKKB-si1 were 5′-CCG
ACA UUG UGG ACU UAC AdT dT, dTd TGG CUG UAA
CAC CUG AAU GU-5′, and the duplex sequences of IKKB-
si2 were 5′-GCU UAG AUA CCU UCA UGA AdT dT, dTd
TCG AAU CUA UGG AAG UAC UU-5′. HTFs were plated
in six well plates with a density of 6×105 cells per well and
incubated for 12 h. Subsequently, the culture media were
replaced with serum- and antibiotic-free DMEM 2 h before
transfection. CS-g-(PEI-b-mPEG)/IKKΒ-si1 and CS-g-(PEI-
b-mPEG)/IKKΒ-si2 complexes were prepared at an N/P ratio
of 10 30 min before transfection, and cells were incubated with
serum- and antibiotic-free DMEM that contained complexes
corresponding  to  the  determined  final  concentrations  of
IKKΒ-si1 or IKKΒ-si2 (5, 10, 25, 50, and 100 nM) for 6 h.
Then, the cells were maintained in serum-supplied DMEM for
another  24  h  or  48  h  before  the  following  assays  were
performed as described below. Non-transfected HTFs were
regarded as the control, and cells were also transfected with
100 nM of scrambled siRNA.
Real-time reverse transcription polymerase chain reaction:
Total RNA was extracted from 1×105 to 2×105 HTFs 24 h after
the  transfection  medium  was  removed  using  the  RNeasy
Micro  Kit  (Qiagen  Inc.,  Valencia,  CA)  according  to  the
manufacturer’s protocol. The yield and purity of the RNA
were spectrophotometrically determined, and the cDNA were
prepared using the ReverAidTM First Strand cDNA Synthesis
Kit  (Fermentas  Inc.,  Hanover,  MD).  A  real-time  reverse
transcription polymerase chain reaction (RT–PCR) procedure
was conducted according to the manufacturer’s protocol for
the SYBR® Premix Ex TaqTM Kit (Takara Biotechnology,
Otsu, Shiga, Japan). Reaction participants were assembled in
a 96 well optical reaction plate (Applied Biosystems, Foster
City, CA), and each well contained SYBR® Premix Ex TaqTM
(2X), 200 nM of forward primer, 200 nM of reverse primer,
ROX Reference Dye (50X), and cDNA solution with a total
volume of 20 μl. For IKKβ, the forward primer was 5′-TGT
CAG TGG AAG CCC GGA TAG-3′, and the reverse primer
was 3′-AGG TTA TGT GCT TCA GCC ACC AG-5′. The
mRNA level of glyceraldehydes-3-phosphate dehydrogenase
(GAPDH) was also measured in each sample as an internal
control. The forward primer was 5′-ATC ACC ATC TTC
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Cell viability (%)=(OD570(sample)/OD570(control) x 100CAG GAG CGA-3′, and the reverse primer was 3′-CAG AAG
TGG TGG TAC CTC TTC C-5′. Reactions were performed
under the following conditions: 10 min at 95 °C for the initial
denaturation, 40 cycles of amplification (5 s at 95 °C), and
annealing  for  31  s  at  60  °C,  using  the  ABI  Prism  7000
Sequence  Detection  System  (Applied  Biosystems).  The
threshold cycle (Ct) values were determined by ABI Prism
7000 Software (Applied Biosystems) and were normalized by
subtracting  the  Ct  GAPDH  values.  All  experiments  were
performed in triplicate, and the relative amount of mRNA of
each  sample  was  calculated  using  the  2-ΔCt  method  in
individual experiments [19].
Western blot: Each group of HTFs was lysed in lysis buffer
(60 mM of Tris, 2% SDS, 100 mM of 2-mercaptoethanol, and
0.01%  bromophenol  blue)  48  h  after  the  transfection
procedure. An equal amount of protein (10 µg) was loaded on
12%  sodium  dodecyl  sulfate-polyacrylamide  gel,  and
electrophoresis was performed for 1 h. The proteins were then
electrophoretically transferred to a polyvinylidene diflouride
(PVDF) membrane (Invitrogen, Carlsbad, CA) for probing
with mouse monoclonal anti-IKKβ (BD Bioscience, San Jose,
CA) and horseradish peroxidase (HRP)-conjugated goat anti-
mouse IgG (Santa Cruz Biotechnology Inc., Santa Cruz, CA).
Blotting  signals  were  detected  by  chemiluminescence
reagents  using  an  ECL  kit  (Amersham  Bioscience,
Piscataway, NJ) following the manufacturer’s instructions.
The β-actin protein amount of each sample was also measured
as an internal control.
Confocal laser scanning microscopy: HTFs prepared for the
confocal microscopy study were seeded onto preloaded glass
coverslips (18 mm×18 mm) in six well plates with a density
of  6×105  cells  per  well  and  incubated  for  24  h  to  allow
adhesion.  Then,  100  nM  of  IKKΒ-siRNA  or  100  nM  of
scrambled siRNA were transfected into HTFs as described
above, and after another 24 h, the cells were stimulated with
20 ng/ml of tumor necrosis factor-α (TNF-α) for 1 h. All the
coverslips were taken out 24 h after the TNF-α stimulation
and were rinsed three times with PBS. The cells were then
fixed by incubation with 4% paraformaldehyde solution at
room  temperature  for  10  min  followed  by  10  min
permeabilization  by  0.2%  Triton  X-100  (Sigma-Aldrich).
After blocking the nonspecific binding with goat serum for 30
min, all the samples were incubated with mouse monoclonal
anti-p65 of NF-κB (1:100, Santa Cruz Biotechnology Inc.)
and FITC-conjugated goat anti-mouse IgG (1:200, Santa Cruz
Biotechnology  Inc.)  at  37  °C  for  1  h,  both  under  light
exclusion. The nuclei of the cells were counterstained with
2  µg/ml  of  DAPI  (4’,  6-diamidino-2-phenylindole
dihydrochloride) at room temperature for 10 min under light
exclusion. A Zeiss LSM 510 confocal laser scanning device
(Zeiss,  Oberkochen,  Germany)  was  used  to  capture  the
inflorescence images. Cells not treated with either CS-g-(PEI-
b-mPEG)/siRNA complexes or TNF-α were considered the
negative control, and cells treated with only 20 ng/ml of TNF-
α for 1 h were measured as the positive control.
Cell  proliferation  assay:  The  proliferation  of  HTFs  was
measured  using  Cell  Titer  96®  AQueous  One  Solution  cell
proliferation assay. After siRNA transfection, each group of
HTFs was trypsinized and seeded in a 96 well plate with an
initial density of 5×103 cells per well. Subsequently, cells were
cultured  in  a  serum-supplied  medium  for  72  h,  and  the
absorbance of each sample corresponding to the cell number
was measured.
Statistical analysis: All data are presented as means±standard
deviation (SD). The statistical analyses were conducted using
SPSS version 13.0 for windows (SPSS Science Inc., Chicago,
IL). Statistical analysis was performed using Student’s t-test
or one-way analysis of variance (ANOVA). Probability (p) of
less than 0.05 was considered significant.
RESULTS
The physicochemical properties of CS-g-(PEI-b-mPEG): CS
proton signals appeared at 2.84 ppm (H-2) and 3.3−3.8 ppm
(H-3, 4, 5, 6, 6’; Figure 2B), and the oxidation degree of CS
(q) was calculated by the following equation from the 1H NMR
spectrum:
From the results of GPC (Table 1), the molecular weights of
periodate  oxidation  CS  and  CS-g-(PEI-b-mPEG)  were
Figure 2. The 1H NMR spectra of CS and its derivatives. Spectra
were obtained with 32 scans, and delay of 2 s between pulses. A: CS
in D2O and CF3COOD at 293 K, B: CS-CHO in D2O at 293 K; C:
CS-g-(PEI-b-mPEG) in D2O at 293 K.
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q=(IH2-IH2')/(IH2) x 100%1.16×104  and  2.95×104,  and  the  degree  of  grafted  PEI-b-
mPEG can be calculated by the following equation according
to the data above:
M’W,CS-CHO is the average molecular weight of repeat unit
of CS-CHO.
Particle  sizes  and  zeta  potential  of  the  complexes:  The
diameter  of  the  CS-g-(PEI-b-mPEG)/siRNA  complexes
ranged between 200 nm and 250 nm at the determined N/P
ratios (Figure 3A), which was less than that of 25 kDa PEI at
each N/P ratio. It should be noted that the diameter of the
complexes decreased while the N/P ratios increased from 1 to
10 and then remained constant up to an N/P ratio of 20. The
zeta potential of the complexes increased in parallel with the
rinsing N/P ratio, ranging from −2.4 mV to +26.5 mV. The
complexes prepared at all the determined N/P ratios showed
a lower zeta potential compared with that of the 25 kDa PEI/
siRNA  complexes,  which  was  measured  as  +5.2  mV—
+36.7 mV (Figure 3B).
Condensation and protection ability of CS-g-(PEI-b-mPEG)
for siRNA: The degree of compaction between CS-g-(PEI-b-
mPEG) and siRNA was assessed by visualizing the mobility
of  the  CS-g-(PEI-b-mPEG)/siRNA  complexes  using
electrophoresis retardation assay. As shown in Figure 4, the
migration of the complexes was retarded to different degrees
according  to  the  increasing  concentration  of  the  cationic
copolymer. Partial retardation was observed at N/P ratios of
1-5, and complete retardation occurred at N/P ratios of 10 and
20. The siRNA protection ability of CS-g-(PEI-b-mPEG) was
measured  by  incubating  the  CS-g-(PEI-b-mPEG)/siRNA
complexes with 10% FBS for 2 h, 4 h, 8 h, 12 h, and 24 h. The
remaining intact siRNA was visualized by polyacrylamide gel
electrophoresis (PAGE), and the images of the gels are shown
in  Figure  5A.  The  percentages  of  siRNAs  that  were  not
degraded  compared  with  the  control  (non-FBS  treated
siRNAs) are also calculated and shown in Figure 5B.
Transfection  efficiency  and  cytotoxicity:  Transfection
efficiency  was  evaluated  by  measuring  the  percentage  of
HeLa  cells  or  HTFs  containing  FITC-conjugated  siRNA,
using flowmetry 6 h after CS-g-(PEI-b-mPEG) or 25 kDa PEI/
siRNA complexes were added. As shown in Figure 6, both the
transfection efficiency of CS-g-(PEI-b-mPEG) and 25 kDa
PEI increased as the N/P ratio increased. The transfection
efficiency  of  CS-g-(PEI-b-mPEG)  reached  its  peak  (more
than 60%) at the N/P ratio of 20 in both cell lines. However,
it could not be calculated when 25 kDa PEI was used for
transfection at the same N/P ratio because most cells had been
killed. A tetrazolium-based viability assay, which was based
on the bioreduction of the MTS reagent into formazan by
living cells, was used to study the cytotoxicity of CS-g-(PEI-
b-mPEG) and 25 kDa PEI. The pure CS-g-(PEI-b-mPEG)
copolymer  exhibited  cell  viability  of  more  than  70%  at
concentrations of 1–100 μg/ml, and the number of viable cells
was significantly higher than those treated with pure 25 kDa
PEI at concentrations of 10 μg/ml and above (Figure 7A).
Figure 3. The effects of N/P ratio on the hydrodynamic diameter and
zeta-potential  of  CS-g-(PEI-b-mPEG)/siRNA  complexes  and  25
kDa PEI/siRNA complexes. The diameter of complexes decreased
while the N/P ratios increased from 1 to 10 and then remained
constant up to N/P of 20; the zeta-potential of complexes increased
in parallel with the rinsing N/P ratio. A: hydrodynamic diameter
(mean±SD, n=3); B: zeta-potential (mean±SD, n=3).
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TABLE 1. CHARACTERISTICS OF PREPARED CS-g-(PEI-b-mPEG).
Degree of oxidation
(CS; mol %)*
Mw of periodate- oxidation CS
(CS-CHO)**
Mw of CS-g-(PEI-b-mPEG)** Degree of grafted PEI-b-mPEG
(mol %)**
36 1.16×104 2.95×104 8.1
The asterisk means that it was determined by 1H NMR, and a double asterisk indicates that it was determined by GPC.
q=[(MW,CS-g-(PEI-b-mPEG)-MW,CS-CHO)/MW,PEI- b
-mPEG]/(MW,CS-CHO/M'W,CS-CHO) x 100%Figure 7B reveals that both the CS-g-(PEI-b-mPEG)/siRNA
and 25 kDa PEI/siRNA complexes presented less toxicity
after being compacted with siRNAs, and the CS-g-(PEI-b-
mPEG)/siRNA  complexes  also  performed  decreasing
cytotoxicity at all the determined N/P ratios compared with
that of the 25 kDa PEI/siRNA complexes.
Downregulating effect on IKKβ expression: In our primary
experiments, we found that IKKΒ-si1 is more effective than
IKKΒ-si2 in downregulating the transcription of IKKβ mRNA
(data not shown), so we used IKKΒ-si1 as IKKΒ-siRNA in
the  subsequent  RNAi  procedures.  Real-time  PCR  assay
revealed that mRNA transcription of IKKβ in the HTFs was
suppressed in a dose-dependent manner 24 h after 5–100 nM
of IKKΒ-siRNA were transfected (Figure 8A). Significant
inhibition (43%) was detected following transfection of 10
nM of IKKΒ-siRNA compared to the control group (p<0.05),
and maximum suppression (55%) was observed in the group
transfected  with  50  nM  of  IKKΒ-siRNA.  In  addition,  no
significant difference between the mRNA level of IKKβ was
detected in multiple experiments following 50 nM and 100
nM of IKKΒ-siRNA transfection, and cells transfected with
100  nM  of  scrambled  siRNA  expressed  a  level  of  IKKβ
mRNA similar to that of the control group. Meanwhile, the
IKKβ protein level was demonstrated by western blot assay
48 h after 5–100 nM of IKKΒ-siRNA were transfected into
the HTFs. The expression of IKKβ protein was inhibited in a
dose-dependent manner after IKKΒ-siRNA transfection into
the  HTFs  whereas  no  significant  difference  was  found
between the expression level of β-actin in HTFs that were and
were not transfected (Figure 8B).
Inhibiting effect on the activation of NF-κB: The activation of
NF-κB  was  determined  by  immunocytochemical  imaging.
Immunofluorescence  detected  by  confocal  laser  scan
microscopy showed that activated NF-κB were present in both
Figure  4.  The  electrophoretic  mobility  of  CS-g-(PEI-b-mPEG)/
siRNA complexes. The complete retardation is indicated by the white
arrow head.
the cytoplasm and nuclei of normal HTFs (Figure 8C-E), and
after  stimulation  with  TNF-α,  most  translocated  into  the
nuclei  (Figure  8F-H).  After  transfection  with  100  nM  of
IKKΒ-siRNA for 72 h, no more activated NF-κB could be
seen in the nuclei of the HTFs after the stimulation with TNF-
α whereas many were still present in the cytoplasm (Figure
8L-N).  In  contrast,  inhibition  of  the  activation  and
translocation of NF-κB was not found in HTFs transfected
with 100 nM of scrambled siRNA (Figure 8I-K).
Inhibiting  the  proliferation  of  human  Tenon’s  capsule
fibroblasts  by  RNAi  targeting  IKKβ:  The  RNAi  process
targeting IKKβ repressed the proliferation of HTFs in a siRNA
dose-dependent manner in vitro. The cell viability of HTFs
transfected with more than 50 nM of IKKΒ-siRNA showed
significant  differences  compared  with  that  of  the  control
group (p<0.05) as shown in Figure 9 whereas the proliferation
of HTFs transfected with 100 nM of scrambled siRNA was
not affected.
Figure 5. The protection ability of CS-g-(PEI-b-mPEG) for siRNA
against  serum  degradation.  The  images  of  intact  siRNAs  at
determined time intervals are shown (A), and the percentage of intact
siRNAs in reference to the non-FBS treated control is also calculated
(B, mean±SD, n=3).
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Glaucoma filtration surgery often fails because of excessive
scarring that occurs during the wound healing process. After
filtration  surgery,  fibroblasts  are  activated  by  various
cytokines  and  growth  factors,  eventually  resulting  in  the
closure  of  the  drainage  channel.  Thus,  preventing  the
hyperfunction  of  fibroblasts  is  an  important  strategy  for
minimizing subconjunctival scarring [20,21]. Current anti-
scarring therapies focus on suppressing the proliferation of
fibroblasts through anti-metabolic agents such as mitomycin
C  (MMC)  and  5-fluorouracil  (5-Fu).  The  perioperative
administration  of  such  agents  has  greatly  improved  the
success rate of filtration surgery [22,23]. However, they are
associated  with  several  severe  complications  including
Figure 6. The transfection efficiency of CS-g-(PEI-b-mPEG) and 25
kDa PEI at different N/P ratios in HeLa cells and HTFs. Data are
presented as the percentage of HeLa cells or HTFs containing FITC-
conjuncted siRNA, respectively, and data of 25 kDa PEI/siRNA
complexes at N/P ratio of 20 can’t be measured (not available, NA).
A:  transfection  efficiency  in  HeLa  cells  (mean±SD,  n=3);  B:
transfection efficiency in HTFs (mean±SD, n=3).
keratitis, bleb leakage, chronic hypotony with maculopathy,
and endophthalmitis [24].
One  goal  of  our  study  was  to  find  new  physiologic
approaches  to  limiting  excessive  subconjunctival  wound
healing that are as effective as antimetabolic agents but have
fewer adverse effects. NF-κB is a member of the transcription
factor family NF-κB/Rel and was originally described as a
necessary element for the transcription of the immunoglobulin
Figure 7. Cytotoxicity of CS-g-(PEI-b-mPEG) and 25 kDa PEI at
various concentrations of pure polymers and complexes with siRNA
at determined N/P ratios. Pure CS-g-(PEI-b-mPEG) copolymer did
not exhibit significant cytotoxicity at any determined concentration,
and  after  compacting  with  siRNAs,  both  CS-g-(PEI-b-mPEG)/
siRNA  and  25  kDa  PEI/siRNA  complexes  showed  much  lower
cytotoxicity. A: Cytotoxicity of various concentrations of pure CS-
g-(PEI-b-mPEG) or 25 kDa PEI polymers; B: cytotoxicity of CS-g-
(PEI-b-mPEG)/siRNA  or  25  kDa  PEI/siRNA  complexes  at
determined N/P ratios. Data are presented as the percentage of viable
cells  compared  with  the  untreated  (control)  cells  (The  asterisk
indicates a p<0.05, mean ± SD, n=6).
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proved  to  be  a  ubiquitous  factor  associated  with  wound
healing through the factor’s ability to stimulate transcription
Figure 8. IKKΒ-siRNA inhibits the expression of IKKβ on both the
mRNA and protein level. A: mRNA transcription of IKKβ in HTFs
assessed by real-time RT-PCR 24 h after 5-100 nM IKKΒ-siRNA
was  transfected.  The  normalized  IKKβ  mRNA  level  of  non-
transfected HTFs is taken as 1.0 (the asterisk indicates a p<0.05,
mean±SD, n=3). B: Protein levels of IKKβ demonstrated by western
blot. C-N: Confocal laser scanning microscopy images shows the
intracellular distribution of NF-κB in HTFs. Green fluorescence
indicates the intracellular distribution of phosphated NF-κB, and
blue fluorescence represents the DAPI counterstained cell nuclei.
of various genes involved in the activation of inflammation
and cell proliferation [26,27]. Thus, we thought the NF-κB
pathway may be an essential factor in the regulation of the
proliferation of HTFs after glaucoma filtration surgery. NF-
κB is bonded with an inhibitor protein, IκB, which sequesters
NF-κB in an inactive form in the cytoplasm. A specific IκB
kinase, IKK, is a protein complex that contains three subunits,
and  studies  indicate  that  IKKβ  is  indispensable  for  the
activation  of  NF-κB  [28].  IKK  phosphorylates  IκB  and
initiates  the  inhibitor’s  conjugation  to  ubiquitin  and
subsequent degradation by proteasomes. In turn, NF-κB is
activated through release from IκB and translocates into the
nuclei [29]. RNAi is commonly used as a powerful tool in
biological and biomedical research [30] and has been used
experimentally  to  prevent  ocular  neovascularization  and
inflammation  [31,32].  Researchers  in  our  group  have
successfully  inhibited  the  proliferation  of  HTFs  through
specifically downregulating the expression of IKKβ using a
commercial  transfection  reagent,  LipofectamineTM  2000
(Invitrogen, Carlsbad, CA), as a siRNA-delivering vector.
However, this cationic liposome compound cannot be used
for in vivo investigation in humans [33].
Therefore, another objective of our study was to design
and  synthesize  new  compounds  that  are  non-toxic,  non-
immunogenic, degradable, and efficient for delivering siRNA
into  HTFs.  Among  non-viral  nucleotide  carriers  currently
under investigation, PEI is one kind of synthetic polymer with
a high cationic charge density and a protonable amino group
in every third position. PEI can condense and compact DNA
into complexes, and the strong proton capacity of PEI allows
it  to  deliver  plasmid  DNA  and  oligonucleotides  into
mammalian cells, both in vitro and in vivo [34]. However,
despite having effective delivery capacity, high molecular
Figure 9. The inhibition effect of blocking NF-κB pathway on the
proliferation  of  HTFs  through  RNAi.  Data  are  presented  as  the
percentage of viable cells compared with the untreated (control) cells
(mean ± SD, n=6). An asterisk indicates that p<0.05.
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cationic charge density also makes PEI toxic to cells [35].
Therefore, the current trend is toward using modified low
molecular weight PEI as a nucleotide delivery reagent, which
combines  high  biocompatibility  and  reduced  cytotoxicity
[36,37].  PEG,  a  nonionic  hydrophilic  polyether,  has  been
widely investigated as a synthesizing graft copolymer with
PEI. The nonionic PEG chains can serve as a hydrophilic shell,
which makes the new copolymer more soluble and stable, and
reduces  its  non-specific  interaction  with  proteins  in
physiologic fluids [38,39]. One drawback of these copolymers
for in vivo application is their lack of transfection efficiency.
Chitosan  is  the  name  given  to  a  group  of  linear  cationic
polymers of glucosamine and N-acetylglucosamine that are
derived  from  the  natural  biopolymer,  chitin,  by  alkaline
deacetylation.  Chitosan  has  been  investigated  as  a  food
additive  or  a  wound  dressing,  and  it  has  been  recently
considered to be a good candidate for gene delivery because
of its reported biocompatibility and biodegradability and its
relatively non-toxic nature [40].
In  light  of  these  results,  we  speculated  that  a  novel
cationic copolymer combined with PEI, PEG, and CS could
be  synthesized  as  a  vehicle  for  delivering  siRNA  into
mammalian cells effectively and safely. In our research, we
found that after the grafting reaction, characteristic absorption
of PEI and mPEG appeared at 2.5−3.3 ppm and 3.5 ppm in the
1H NMR spectrum of the copolymer, respectively. CS proton
absorption signals (H-2, H-3, 4, 5, 6, 6’, 2.8−3.8 ppm) also
overlapped the PEI and mPEG proton signals (Figure 2). All
of the data above prove that the designed CS-g-(PEI-b-mPEG)
copolymer was successfully obtained. The molecular weight
of CS-g-(PEI-b-mPEG) was 2.95×104, which was relatively
larger than some reported PEI-alt-PEG copolymers [41] but
smaller than generally used PEI [37].
As indicated in previous reports, the size and shape of
nanoparticles play an important role in the delivery process
and greatly influence distribution in the body [42]. It has been
reported that the nano-size of particles is a key prerequisite
for  cell  uptake  [43].  Similar  to  plasmid  DNA  and
oligonucleotides,  siRNAs  are  taken  up  by  cells  through
endocytosis. Therefore, suitable particle size has an important
influence on the delivering capacity of a siRNA vector. We
investigated the diameter of the CS-g-(PEI-b-mPEG)/siRNA
complexes at five different N/P charge ratios and observed
that the complexes represented particles with nanometer size
(about 200 nm), which were much less than that of 25 kDa
PEI. Furthermore, particle size tended to decrease as the N/P
charge ratios of the CS-g-(PEI-b-mPEG)/siRNA complexes
increased, indicating that the CS-g-(PEI-b-mPEG) copolymer
can condense siRNA into a more compact structure, mainly
owing  to  the  net  electrostatic  repulsive  forces  between
complexes.
The surface charge of the CS-g-(PEI-b-mPEG)/siRNA
complexes  is  also  a  major  factor  influencing  transfection
efficiency.  After  the  compaction  between  cationic
copolymers  and  siRNA,  the  negative  charge  of  siRNA  is
neutralized and the newly assembled nanoparticles may retain
a partial positive surface charge to help siRNA pass through
the cell membrane and escape the endolysosomes. However,
the  excessive  positive  charge  of  PEI  homopolymers  may
subsequently  lead  to  hyperpermeability  of  the  membrane,
resulting in cell death [44]. The density of the surface charge
is reflected by measured zeta potential values, and as we have
shown, an initial negative value of zeta potential (−2.4 mV)
was detected when the complexes formed at an N/P ratio of
1,  which  means  that  siRNA  could  not  be  completely
compacted under this condition. Then, the positive surface
charge  of  the  complexes  exhibited  an  increasing  trend
corresponding to the rising N/P ratio, indicating that more and
more siRNAs were compacted with CS-g-(PEI-b-mPEG) and
the negative charge was neutralized. But the zeta potential of
the CS-g-(PEI-b-mPEG)/siRNA complexes at each N/P ratio
that we measured was still lower than that of the 25 kDa PEI/
siRNA  complexes.  The  reason  for  this  result  is  probably
consistent  with  the  reason  Petersen  et  al.  [8]  regarding
copolymer-based  DNA  complexes,  which  was  that  the
shielding effect of neutral components on the PEI part of the
copolymer produces a relatively low zeta potential.
Condensation ability is one requirement for a siRNA
carrier.  An  optimal  binding  degree  between  CS-g-(PEI-b-
mPEG)  and  siRNA  can  achieve  more  efficient  delivering
capacity. If the complexes are formed efficiently, all siRNAs
are bound to the copolymers to form nanoparticles. Hence, the
complexes become relatively large and remain immobile in
the loading well with no bands of free siRNA apparent. We
observed that the migration of siRNA was retarded to different
degrees in accordance with the increasing N/P ratio. Complete
retardation occurs at an N/P ratio of 10, which means the CS-
g-(PEI-b-mPEG)/siRNA complexes are completely formed.
The complete complexes of 600 kDa PEI and siRNA cannot
be found even at an N/P ratio of 50 (data not shown), which
indicates that the condensation ability of CS-g-(PEI-b-mPEG)
is better than low molecular weight PEI. It was also detected
that the band of siRNA at an N/P ratio of 20 demonstrated
much lower fluorescence intensity than that of the band at the
N/P  ratio  of  10.  This  decrease  in  fluorescence  was  also
observed by other experiments executed on DNA bands [8,
45]. The reason for this phenomenon is that the measured
fluorescence is attributed to the intercalated ethidium bromide
in siRNA. When the condensation degree between siRNA and
the cationic copolymer gradually increases, ethidium bromide
cannot  intercalate  with  siRNA  anymore.  Therefore,  the
fluorescence  intensity  of  the  bands  decreases  accordingly
[39].
The main hindrance to the use of RNAi as a therapeutic
tool for human diseases is that the unprotected dsRNA or
siRNA will be rapidly degraded by either nucleases in serum
or  the  endosomal  compartment  of  cells.  The  enzymatic
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biological activity and therapeutic efficiency. Therefore, the
potential  of  this  technology  as  a  clinical  therapy  method
depends  largely  on  the  improvement  of  siRNA  vectors’
protection ability against enzymatic degradation. We found
that after incubation in 10% FBS for 24 h, 64% of siRNA was
protected from degradation at the N/P ratio of 20 whereas only
0.7%  naked  siRNA  remained  intact.  We  attributed  these
results to two factors. First, PEG not only has the reported
ability to stabilize the structure of nanospheres, but PEG can
also protect siRNA from being attacked by nucleases [46,
47]. Second, it has been reported that chitosan can effectively
protect DNA from nuclease degradation [48]. The CS-g-(PEI-
b-mPEG) we have synthesized has both PEG and CS elements
and  can  provide  efficient  protection  for  siRNA  against
enzymatic degradation.
Low toxicity is also a major requirement for an siRNA
delivery system. The cytotoxicity of cationic copolymers is
mainly caused by the aggregation of nanoparticles on the cell
membrane, impairing its normal function. In addition, the
excessive positive surface charge of nanoparticles may also
interfere with critical intracellular processes of cells [44]. It
has been shown that chitosan salts and chitosan derivatives
are less toxic than PEI [49]. However, no data have been
reported  regarding  the  cytotoxic  analysis  of  a  synthetic
cationic copolymer on human Tenon’s capsule fibroblasts.
Therefore,  we  explored  the  influence  of  different
concentrations of CS-g-(PEI-b-mPEG) and 25 kDa PEI on the
cell viability of HTFs. CS-g-(PEI-b-mPEG) showed much
less cytotoxicity than 25 kDa PEI, which is consistent with
what had been obtained by Kim et al. [18] in tests of HeLa
and HepG2 cells. The cell viabilities of the HTFs decreased
drastically as the concentrations of 25 kDa PEI increased
whereas  the  pure  CS-g-(PEI-b-mPEG)  copolymer  did  not
exhibit  significant  cytotoxicity  at  any  determined
concentration.  We  hypothesize  that  the  relatively  low
cytotoxicity of CS-g-(PEI-b-mPEG) could be explained from
two aspects. First, the copolymer can be degraded into CS,
PEG, and low molecular weight PEI units in cells, all of which
can be easily eliminated by excretion pathways, thus making
this copolymer relatively less toxic than 25 kDa PEI. Second,
PEG reduces toxicity by substituting the amino groups of PEI,
which are the main toxic moieties of the copolymer [50].
Furthermore, after compacting with siRNA, both the CS-g-
(PEI-b-mPEG)/siRNA  and  25  kDa  PEI/siRNA  complexes
showed  much  lower  cytotoxicity,  which  is  due  to  the
neutralization effect of the negative charge of siRNA on the
positive charge of the pure polymers.
The transfection efficiency of the CS-g-(PEI-b-mPEG)/
siRNA complexes was assessed at various N/P ratios in HeLa
cells and HTFs. This is mainly because the N/P ratio is directly
related to the size, surface charge, compaction degree, and
serum-resistant capacity of the CS-g-(PEI-b-mPEG)/siRNA
complexes, all of which can affect delivery efficiency. At the
N/P  ratio  of  20,  CS-g-(PEI-b-mPEG)  outperformed  the
highest transfection rate in both HeLa cells and HTFs, which
can be explained by the appropriate particle size and surface
charge as well as the excellent stability of the CS-g-(PEI-b-
mPEG)/siRNA complexes. The transfection rate was a little
lower than that of 25 kDa PEI at the same N/P ratio partly
because of the shielding effect of mPEG on the positive charge
of PEI. We also found that both CS-g-(PEI-b-mPEG) and
25 kDa PEI showed a lower transfection rate in HTFs than in
HeLa cells, which may be attributed to a cell line dependency
of  the  cationic  polymer’s  delivery  ability  [51].  From  our
results, we can conclude that PEI with low molecular weight
grafted onto CS avoids the cytotoxicity of high molecular
weight PEI. Meanwhile, mPEG improves the stability of CS-
g-(PEI-b-mPEG)/siRNA complexes, and as a result, the CS-
g-(PEI-b-mPEG)/siRNA nanoparticles can offer a substantial
gene silencing effect with minimal side effects. Moreover,
many factors governing the transfection efficiency of cationic
copolymers need to be investigated in future studies such as
the presence of serum and the pH value of solution [52], and
ligands  will  be  conjugated  to  the  copolymers  to  achieve
receptor-mediated endocytosis and potentially to target cells
or tissues.
A special siRNA targeting IKKβ gene was successfully
compacted  with  CS-g-(PEI-b-mPEG)  and  effectively
delivered  into  HTFs.  Subsequently,  both  the  mRNA  and
protein levels of IKKβ were suppressed, and the activation of
NF-κB was inhibited in turn. Finally, IKKΒ-siRNA-mediated
blocking of the NF-κB pathway resulted in repression of the
proliferation  of  HTFs,  and  cells  transfected  with  IKKΒ-
siRNA showed growth inhibition up to 42%. All of these
findings suggest that blocking the signaling pathway of NF-
κB could be an effective way to manipulate the scar formation
process by downregulating the proliferation of HTFs. This
novel  method  based  on  nanotechnology  and  RNAi  could
represent a remarkable anti-scarring therapeutic approach for
glaucoma filtration surgery. Follow-up studies will focus on
the in vivo application of CS-g-(PEI-b-mPEG)/IKKΒ-siRNA
complexes.
We have reported on the synthesis and characterization
of  a  novel  cationic  copolymer,  CS-g-(PEI-b-mPEG).  We
found  it  to  have  powerful  siRNA  binding  and  protection
ability,  relatively  high  transfection  efficiency,  and  low
cytotoxicity, making CS-g-(PEI-b-mPEG) a suitable delivery
vector for transfecting siRNA into cells. We observed that
siRNA  targeting  IKKβ  was  successfully  transfected  into
human  Tenon’s  capsule  fibroblasts  in  vitro,  and  RNAi
processes against the expression of IKKβ can subsequently
inhibit the activation of NF-κB and in turn, the proliferation
of HTFs. Our results indicate the potential for a safe and
effective  strategy  for  preventing  scar  formation  after
glaucoma filtration surgery.
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